期刊文献+

同步放化疗治疗直肠癌的疗效及毒副作用分析 被引量:5

Analysis of the clinical efficacy and toxicity of concurrent chemotherapy in the treatment of colorectal cancer
原文传递
导出
摘要 目的 探讨序贯与同步放化疗分别治疗直肠癌的临床疗效及毒副作用.方法 选取90例直肠癌患者,根据疾病分期标准分为Ⅱa期21例(Ⅱa组)、Ⅲa期24例(Ⅲa组)、Ⅱb期23例(Ⅱb组)、Ⅲb期22例(Ⅲb组).Ⅱa组和Ⅲa组患者使用序贯放化疗治疗,Ⅱb组和Ⅲb组使用同步放化疗治疗,分别比较患者的临床疗效和毒副反应发生情况.结果 所有患者的1年和3年随访无1例失访及死亡情况.Ⅱa组和Ⅱb组的1年和3年的总生存时间(OS)与无进展生存时间(PFS)差异均无统计学意义(均P>0.05);Ⅲa组与Ⅲb组的1年OS差异无统计学意义(P>0.05),1年PFS、3年OS以及3年PFS差异均有统计学意义(χ2=3.993、4.224、4.304,均P<0.05);Ⅱa组+Ⅲa组的毒副反应发生率(28.89%)与Ⅱb组+Ⅲb组的毒副反应发生率(51.11%)差异有统计学意义(χ2=4.629,P<0.05),对于各系统具体的毒副反应发生率差异无统计学意义(P>0.05).结论 与序贯放化疗相比,在直肠癌的治疗中,同步放化疗能有效延长患者的OS和PFS,虽增加了患者治疗后的毒副反应,但仍在患者可接受范围内,临床上具有更好的应用价值. Objective To investigate the clinical efficacy and side effects of sequential and concurrent chemoradiation in the treatment of colorectal cancer.Methods 90 patients with colorectal cancer were divided into ⅡAof 21 cases (Ⅱa group),Ⅲa of 24 cases (Ⅲa group),Ⅱb of 23 cases (Ⅱb group),Ⅲb of 22 cases (Ⅲa group) according to the stage of the disease.Group Ⅱa and Ⅲa were treated by sequential chemoradiation therapy,Ⅱb group and Ⅲb group were treated by concurrent chemoradiation therapy.The clinical efficacy and toxicity were observed and compared.Results All patients were followed up at 1 and 3 years,no one lost and died.1-year and 3-year OS and PFS between group Ⅱa and group Ⅱb had no significant differences (P 〉 0.05).1-year OS had no significant difference between Ⅲa group and Ⅲb group (P 〉 0.05),1-year PFS,3-year OS and PFS had significant differences (χ2 =3.993,4.224,4.304,all P 〈 0.05).The incidence rate of toxicities between Ⅱa group +Ⅲa group (28.89%) and group Ⅱb+ Ⅲb (51.11%) had significant difference (χ2 =4.629,P 〈 0.05) ; while for each system specific incidence rate of side effects had no significant difference (P 〉 0.05).Conclusion Compared with sequential chemotherapy in the treatment of colorectal cancer,concurrent chemoradiotherapy can effectively prolong overall survival and progression-free survival time,and can reduce the costs of treating,although increasing the treatment toxicity,but still within the acceptable range of patients,it has better application value in clinical.
出处 《中国基层医药》 CAS 2014年第13期1924-1926,共3页 Chinese Journal of Primary Medicine and Pharmacy
关键词 直肠肿瘤 放射疗法 药物疗法 Rectal neoplasms Radiotherapy Drug therapy
  • 相关文献

参考文献16

二级参考文献110

共引文献147

同被引文献64

  • 1于亮,王道珍.化疗药物的放射增敏作用研究进展[J].国外医学(肿瘤学分册),2005,32(9):675-677. 被引量:5
  • 2王毓洲,应红艳,赵林,陈书长.局部晚期非小细胞肺癌同步化放疗与序贯化放疗比较的Meta分析[J].循证医学,2007,7(3):152-157. 被引量:14
  • 3Deenen M J, Tol J, Burylo AM, et al. Relationship between single nucleotide polymorphisms and haplotypes in DPYD and toxicity and efficacy of capecitabine in advanced colorectal cancer[ J]. Clin Canc- er Res, 2011,17 ( 10 ) :3455-3468. 被引量:1
  • 4Esteban JC, Vila-Casadesus M, Garre P, et al. Whole-exome se- quencing identifies rare pathogenic variants in new predisposition genes for familial colorectal cancer[ J]. Genet Med, 2014,2 ( 1 Sup- pl) : 132-137. 被引量:1
  • 5Glimelius B, Garmo H, Berglund A, et al. Prediction of irinotecan and 5-fluorouracil toxicity and response in patients with advanced colorectal cancer[ J]. Pharmacogenomics J, 2011,11 ( 1 ) :61-71. 被引量:1
  • 6Toole A, Michielsen AJ, Nolan B, et al. Tumour microenvironment of both early- and late-stage colorectal cancer is equally immunosup- pressive[ J]. Br J Cancer, 2014,111 (5) :927-932. 被引量:1
  • 7Cristobal I, Madoz-Gurpide J, Martin-Aparicio E, et al. The tumour suppressor miR-133b is markedly downregulated in liver metastatic colorectal cancer [ J ]. Br J Cancer, 2014,111 (4) :756-762. 被引量:1
  • 8Garg MB, Lincz LF, Adler K, et al. Predicting 5-fluorouracil toxicity in cotorectal cancer patients from peripheral blood cell telomere length: a multivariate analysis [ J ]. Br J Cancer, 2012,107 (9) : 1525-1533. 被引量:1
  • 9Zhang X, Sun B, Lu Z. Evaluation of clinical value of single nucleotide polymorphisms of dihydmpyrimidine dehydrogenase gene to predict 5-flu- ororo'acil toxicity in 60 colorectal cancer patients in China[J]. lnt J Med Sci, 2013,10(7) :894-902. 被引量:1
  • 10Gun laugson A, Kjellen E, Nilsson P, et al. Dose-volume relation- sh ipsbetw eenen teritis and irradiated bowel volumes during 5- fluorouraciland oxalip lat in based chem oradiotherapy in locally advanced rectalcancer[ J ]. Acta One J,2007,46 (7) :937-944. 被引量:1

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部